Metabolic syndrome and the risk of cholangiocarcinoma: a hospital-based case–control study in China

BACKGROUND: Metabolic syndrome is regarded as a risk factor for hepatocellular carcinoma. However, no research has been conducted to investigate the association between metabolic syndrome and cholangiocarcinoma (CCA), especially in the Chinese population. Herein, a hospital-based case–control study...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Jianping, Lu, Xin, Xu, Weiyu, Bai, Yi, Huang, Hanchun, Bian, Jin, Zhang, Lei, Long, Junyu, Xu, Yiyao, Wang, Zhenjie, Zhao, Haitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161710/
https://www.ncbi.nlm.nih.gov/pubmed/30288116
http://dx.doi.org/10.2147/CMAR.S175628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161710/
https://www.ncbi.nlm.nih.gov/pubmed/30288116
http://dx.doi.org/10.2147/CMAR.S175628

Ejemplares similares